Is bursitis treated with intravenous (IV) or oral antibiotics?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Bursitis should be treated with oral antibiotics for mild to moderate cases, and intravenous antibiotics for severe cases, with the goal of transitioning to oral therapy as soon as possible, as recommended by the 2018 WSES/SIS-E consensus conference 1. When deciding between oral and intravenous antibiotics for bursitis, the severity of the infection is the key factor.

  • For mild to moderate septic bursitis, oral antibiotics such as dicloxacillin, cephalexin, or clindamycin are typically the first-line treatment, with a duration of 7-14 days.
  • For more severe cases, particularly those with systemic symptoms, extensive cellulitis, or immunocompromised patients, intravenous antibiotics such as cefazolin, vancomycin, or ampicillin-sulbactam are recommended. The choice of antibiotic should target Staphylococcus aureus, the most common causative organism, though coverage may need to be broadened based on clinical circumstances, as outlined in the 2014 practice guidelines for the diagnosis and management of skin and soft tissue infections by the Infectious Diseases Society of America 1. In addition to antibiotics, treatment should include rest, elevation, ice application, and possibly drainage of the infected bursa.
  • Patients should be monitored for improvement within 48-72 hours, and antibiotic therapy may need adjustment based on culture results and clinical response.
  • Once improvement is noted with IV antibiotics, patients can often be transitioned to oral therapy to complete a full 10-14 day course, as suggested by the 2018 WSES/SIS-E consensus conference 1.

From the Research

Bursitis Treatment Options

  • Bursitis can be treated with antibiotics, either orally or intravenously, depending on the severity of the condition 2, 3, 4.
  • Septic bursitis, in particular, requires prompt antibiotic treatment to prevent further complications 3, 4.
  • The choice of antibiotic and route of administration may vary depending on the specific type of bursitis and the patient's overall health status 3, 5.

Antibiotic Administration

  • Oral antibiotics may be sufficient for mild cases of septic bursitis, while intravenous antibiotics may be necessary for more severe cases 2, 3.
  • Sequential intravenous administration of antibiotics, such as cefazolin, followed by oral antibiotics, such as clindamycin, may be an effective treatment approach for septic bursitis 3.
  • The duration of antibiotic treatment should be based on the culture results of serial aspirations and the patient's clinical response to treatment 4.

Comparison of Treatment Approaches

  • Nonsurgical management of olecranon bursitis, including antibiotic treatment and aspiration, may be more effective and safer than surgical management 5.
  • Corticosteroid injection for aseptic bursitis may be associated with increased complications and is not recommended as a first-line treatment 5.
  • The choice of prophylactic antibiotics for surgical site infection prevention should be based on the patient's individual risk factors and the specific surgical procedure being performed 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Four common types of bursitis: diagnosis and management.

The Journal of the American Academy of Orthopaedic Surgeons, 2011

Research

Olecranon septic bursitis managed in an ambulatory setting. The Calgary Home Parenteral Therapy Program Study Group.

Clinical and investigative medicine. Medecine clinique et experimentale, 2001

Research

Treatment of olecranon bursitis: a systematic review.

Archives of orthopaedic and trauma surgery, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.